Prevalence and conditions of selection of the K65R mutation in the reverse transcriptase gene of HIV-1.
Segondy
Michel
M
Montes
Brigitte
B
D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019943:Amino Acid Substitution; D019380:Anti-HIV Agents / Q000627:therapeutic use; D024882:Drug Resistance, Viral / Q000235:genetics; D005787:Gene Frequency; D005814:Genes, Viral; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology; D054303:HIV Reverse Transcriptase / Q000235:genetics*; D015497:HIV-1 / Q000187:drug effects / Q000201:enzymology* / Q000235:genetics*; D006801:Humans; D063065:Organophosphonates / Q000627:therapeutic use; D017354:Point Mutation; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D012641:Selection, Genetic; D000068698:Tenofovir
D019380:Anti-HIV Agents; D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D000068698:Tenofovir; D054303:HIV Reverse Transcriptase; D000225:Adenine